SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Eli Lilly and Company Release: Studies Assess Linagliptin Treatment in Adults With Type 2 Diabetes (T2D), as Well as Add-on to Basal Insulin Therapy